Beryl Drugs Limited announced earnings results for the fourth quarter ended March 31, 2021. For the fourth quarter, the company announced total revenue was INR 56.745 million compared to INR 31.099 million a year ago. Operating loss was INR 1.362 million compared to INR 6.166 million a year ago. Net income was INR 1.172 million compared to net loss of INR 5.216 million a year ago. Basic earnings per share from continuing operations was INR 0.23 compared to basic loss per share from continuing operations of INR 1.03 a year ago. For the full year, total revenue was INR 142.800 million compared to INR 130.482 million a year ago. Operating loss was INR 1.039 million compared to operating Income of INR 1.579 million a year ago. Net income was INR 2.396 million compared to INR 479,000 a year ago. Basic earnings per share from continuing operations was INR 0.47 compared to INR 0.09 a year ago.